Bar Harbor Wealth Management Sells 491 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Bar Harbor Wealth Management decreased its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 3.2% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 14,826 shares of the financial services provider’s stock after selling 491 shares during the quarter. Bar Harbor Wealth Management’s holdings in iShares Biotechnology ETF were worth $2,159,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in IBB. Mather Group LLC. purchased a new stake in iShares Biotechnology ETF during the 1st quarter worth about $57,000. Banque Cantonale Vaudoise raised its holdings in shares of iShares Biotechnology ETF by 7.9% in the 1st quarter. Banque Cantonale Vaudoise now owns 19,794 shares of the financial services provider’s stock valued at $2,717,000 after acquiring an additional 1,443 shares in the last quarter. Clarus Wealth Advisors raised its holdings in shares of iShares Biotechnology ETF by 5.1% in the 1st quarter. Clarus Wealth Advisors now owns 10,924 shares of the financial services provider’s stock valued at $1,440,000 after acquiring an additional 529 shares in the last quarter. Rye Brook Capital LLC raised its holdings in shares of iShares Biotechnology ETF by 1.0% in the 1st quarter. Rye Brook Capital LLC now owns 40,400 shares of the financial services provider’s stock valued at $5,544,000 after acquiring an additional 400 shares in the last quarter. Finally, &PARTNERS raised its holdings in shares of iShares Biotechnology ETF by 12.7% in the 1st quarter. &PARTNERS now owns 6,383 shares of the financial services provider’s stock valued at $876,000 after acquiring an additional 720 shares in the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.5 %

NASDAQ:IBB opened at $145.69 on Friday. The business’s 50-day moving average price is $145.57 and its two-hundred day moving average price is $139.59. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $150.57.

iShares Biotechnology ETF Announces Dividend

The firm also recently declared a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were issued a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.